Latest Kaiser Health News Stories
The Trump administration is primed to approve a plan designed to help lower costs of some prescription drugs by allowing states to import them from Canada. The announcement could come before Election Day, and Florida appears to be in line to go first.
A KHN review found more than 20 states either don’t count or have incomplete data on the use of COVID-19 antigen tests, leaving the public in the dark about the true scope of the pandemic.
Colorado, Florida and Vermont — with the support of President Donald Trump — are exploring plans to bring drugs across the border from Canada to help lower costs.
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Citing fears of losing federal funds, California is the latest state to require discharge of terminally ill residents from state veterans homes if they plan to end their lives with lethal drugs.
The House Republicans’ bill to repeal Obamacare would change how the federal government allocates matching funds to state Medicaid programs — and could cost some states billions of dollars a year in federal aid.
Vermont embarks on a six-year experiment to redesign health care and how it’s paid for.
Proposed legislation would require drugmakers to disclose and justify price hikes. The industry has taken to Facebook and Twitter, warning that the proposal could lead to medication shortages in some regions of the state.